Form 4: HealthEquity Director Sells Shares in Open Market Transactions

Sentiment:

SEC Form 4 Filing


HealthEquity director Stuart B. Parker sold a total of 25,000 shares of common stock in multiple transactions on December 12, 2024.

Summary

  • Stuart B. Parker, a director at HealthEquity, Inc., sold 24,272 shares of common stock at a weighted average price of $96.6985 per share on December 12, 2024.
  • He also sold 728 shares of common stock at a weighted average price of $97.2997 per share on the same day.
  • The sales were executed in multiple transactions with prices ranging from $96.22 to $97.18 for the first batch and $97.25 to $97.38 for the second batch.
  • Following these transactions, Mr. Parker beneficially owns 19,061 shares of HealthEquity common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by a director, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine disclosure of stock sales by a company director, which is common in the financial industry. It does not indicate any specific trend or issue within the company or the industry.

Comparison to Industry Standards

  • Form 4 filings are standard practice for corporate insiders and are required by the SEC.
  • The transactions are within the normal range of insider trading activity and do not indicate any unusual behavior.
  • Similar filings are made by directors and officers of all publicly traded companies.

Stakeholder Impact

  • The stock sales may have a minor impact on the stock price, but it is unlikely to be significant.

Key Dates

DateDescription
12/12/2024Date of the stock sale transactions.
12/13/2024Date of the filing of the SEC Form 4.

Keywords

HealthEquity, stock sale, insider trading, director, Stuart B. Parker, HQY, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.